Intervention Review

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

  1. Floris A Van de Laar1,*,
  2. Peter LBJ Lucassen2,
  3. Reinier P Akkermans3,
  4. Eloy H Van de Lisdonk4,
  5. Wim JC De Grauw3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 27 FEB 2006

DOI: 10.1002/14651858.CD005061.pub2


How to Cite

Van de Laar FA, Lucassen PLBJ, Akkermans RP, Van de Lisdonk EH, De Grauw WJC. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD005061. DOI: 10.1002/14651858.CD005061.pub2.

Author Information

  1. 1

    Radboud University Nijmegen Medical Centre, Department of General Practice, 117 HAG, Nijmegen, Netherlands

  2. 2

    Radboud University Medical Centre, Department of General Practice and Family Medicine, Nijmegen, Netherlands

  3. 3

    Radboud University Nijmegen Medical Centre , Department of General Practice, 117 HAG, Nijmegen, Netherlands

  4. 4

    Radboud University Medical Centre , Department of General Practice and Family Medicine, Nijmegen, Netherlands

*Floris A Van de Laar, Department of General Practice, 117 HAG, Radboud University Nijmegen Medical Centre, P.O. Box 9101, Nijmegen, 6500 HB, Netherlands. f.vandelaar@cochraneprimarycare.org. f.vandelaar@hag.umcn.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeppe S. Schmidt, Nils T. Nyberg, Dan Staerk, Assessment of constituents in Allium by multivariate data analysis, high-resolution α-glucosidase inhibition assay and HPLC-SPE-NMR, Food Chemistry, 2014, 161, 192

    CrossRef

  2. 2
    Alice Vieira da Costa, Luciana Karen Calábria, Paula de Souza Santos, Luiz Ricardo Goulart, Foued Salmen Espindola, Glibenclamide treatment modulates the expression and localization of myosin-IIB in diabetic rat brain, Journal of the Neurological Sciences, 2014, 340, 1-2, 159

    CrossRef

  3. 3
    Jeppe S. Schmidt, Michael B. Lauridsen, Lars O. Dragsted, John Nielsen, Dan Staerk, Development of a bioassay-coupled HPLC-SPE-ttNMR platform for identification of α-glucosidase inhibitors in apple peel (Malus × domestica Borkh.), Food Chemistry, 2012, 135, 3, 1692

    CrossRef

  4. 4
    E. E. Blaak, J.-M. Antoine, D. Benton, I. Björck, L. Bozzetto, F. Brouns, M. Diamant, L. Dye, T. Hulshof, J. J. Holst, D. J. Lamport, M. Laville, C. L. Lawton, A. Meheust, A. Nilson, S. Normand, A. A. Rivellese, S. Theis, S. S. Torekov, S. Vinoy, Impact of postprandial glycaemia on health and prevention of disease, Obesity Reviews, 2012, 13, 10
  5. 5
    Syed Sikander Azam, Reaz Uddin, Adnan Ali Shah Syed, Zaheer-ul-Haq, Molecular docking studies of potent inhibitors of tyrosinase and α-glucosidase, Medicinal Chemistry Research, 2012, 21, 8, 1677

    CrossRef

  6. 6
    Prise en charge de l’hyperglycémie chez le patient diabétique de type 2 : une stratégie centrée sur le patient, Médecine des Maladies Métaboliques, 2012, 6, III

    CrossRef

  7. 7
    Lei Zhang, Shelly Hogan, Jianrong Li, Shi Sun, Corene Canning, Shao Jian Zheng, Kequan Zhou, Grape skin extract inhibits mammalian intestinal α-glucosidase activity and suppresses postprandial glycemic response in streptozocin-treated mice, Food Chemistry, 2011, 126, 2, 466

    CrossRef

  8. 8
    Mário Raimundo, José António Lopes, Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad, Cardiology Research and Practice, 2011, 2011, 1

    CrossRef

  9. 9
    Lina Felípez, Timothy A. Sentongo, Drug-Induced Nutrient Deficiencies, Pediatric Clinics of North America, 2009, 56, 5, 1211

    CrossRef

  10. 10
    Matthew Potenza, Elliot J. Rayfield, Targeting the Incretin System in Type 2 Diabetes Mellitus, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2009, 76, 3
  11. 11
    A.J. Scheen, Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?, Diabetes & Metabolism, 2007, 33, 1, 3

    CrossRef

  12. 12
    Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007, Revista Española de Cardiología, 2007, 60, 9, 968.e1

    CrossRef

  13. 13
    Suzanne J Grant, Alan Bensoussan, Dennis Chang, Hosen Kiat, Nerida L Klupp, Jian Ping Liu, Xun Li, Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose, The Cochrane Library,
  14. 14
    Sinead Brophy, Helen Davies, Sopna Mannan, Huw Brunt, Rhys Williams, Interventions for latent autoimmune diabetes (LADA) in adults, The Cochrane Library,